373 related articles for article (PubMed ID: 19457814)
1. Renal cell carcinoma: t1 and t2 signal intensity characteristics of papillary and clear cell types correlated with pathology.
Oliva MR; Glickman JN; Zou KH; Teo SY; Mortelé KJ; Rocha MS; Silverman SG
AJR Am J Roentgenol; 2009 Jun; 192(6):1524-30. PubMed ID: 19457814
[TBL] [Abstract][Full Text] [Related]
2. Renal cell carcinoma: dynamic contrast-enhanced MR imaging for differentiation of tumor subtypes--correlation with pathologic findings.
Sun MR; Ngo L; Genega EM; Atkins MB; Finn ME; Rofsky NM; Pedrosa I
Radiology; 2009 Mar; 250(3):793-802. PubMed ID: 19244046
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of T1-Weighted MRI to Detect Intratumoral Hemorrhage Within Papillary Renal Cell Carcinoma as a Feature Differentiating From Angiomyolipoma Without Visible Fat.
Murray CA; Quon M; McInnes MD; van der Pol CB; Hakim SW; Flood TA; Schieda N
AJR Am J Roentgenol; 2016 Sep; 207(3):585-91. PubMed ID: 27275530
[TBL] [Abstract][Full Text] [Related]
4. In-phase signal intensity loss in solid renal masses on dual-echo gradient-echo MRI: association with malignancy and pathologic classification.
Childs DD; Clingan MJ; Zagoria RJ; Sirintrapun J; Tangtiang K; Anderson A; Leyendecker JR
AJR Am J Roentgenol; 2014 Oct; 203(4):W421-8. PubMed ID: 25247971
[TBL] [Abstract][Full Text] [Related]
5. Performance of Relative Enhancement on Multiphasic MRI for the Differentiation of Clear Cell Renal Cell Carcinoma (RCC) From Papillary and Chromophobe RCC Subtypes and Oncocytoma.
Young JR; Coy H; Kim HJ; Douek M; Lo P; Pantuck AJ; Raman SS
AJR Am J Roentgenol; 2017 Apr; 208(4):812-819. PubMed ID: 28125273
[TBL] [Abstract][Full Text] [Related]
6. Are Hemorrhagic Cysts Hyperintense Enough on T1-Weighted MRI to Be Distinguished From Renal Cell Carcinomas? A Retrospective Analysis of 204 Patients.
McKee TC; Dave J; Kania L; Karajgikar J; Masarapu V; Deshmukh S; Roth C
AJR Am J Roentgenol; 2019 Dec; 213(6):1267-1273. PubMed ID: 31532256
[No Abstract] [Full Text] [Related]
7. Predictive Value of Chemical-Shift MRI in Distinguishing Clear Cell Renal Cell Carcinoma From Non-Clear Cell Renal Cell Carcinoma and Minimal-Fat Angiomyolipoma.
Jhaveri KS; Elmi A; Hosseini-Nik H; Hedgire S; Evans A; Jewett M; Harisinghani M
AJR Am J Roentgenol; 2015 Jul; 205(1):W79-86. PubMed ID: 26102422
[TBL] [Abstract][Full Text] [Related]
8. Assessment of Imaging Findings of Renal Carcinoma Subtypes with 3.0T MRI.
Nalbant MO; Inci E
Niger J Clin Pract; 2023 Nov; 26(11):1750-1757. PubMed ID: 38044783
[TBL] [Abstract][Full Text] [Related]
9. Combined late gadolinium-enhanced and double-echo chemical-shift MRI help to differentiate renal oncocytomas with high central T2 signal intensity from renal cell carcinomas.
Cornelis F; Lasserre AS; Tourdias T; Deminière C; Ferrière JM; Le Bras Y; Grenier N
AJR Am J Roentgenol; 2013 Apr; 200(4):830-8. PubMed ID: 23521457
[TBL] [Abstract][Full Text] [Related]
10. Visual Assessment of the Intensity and Pattern of T1 Hyperintensity on MRI to Differentiate Hemorrhagic Renal Cysts From Renal Cell Carcinoma.
Kim CW; Shanbhogue KP; Schreiber-Zinaman J; Deng FM; Rosenkrantz AB
AJR Am J Roentgenol; 2017 Feb; 208(2):337-342. PubMed ID: 27845847
[TBL] [Abstract][Full Text] [Related]
11. Subtype differentiation of renal cell carcinoma using diffusion-weighted and blood oxygenation level-dependent MRI.
Choi YA; Kim CK; Park SY; Cho SW; Park BK
AJR Am J Roentgenol; 2014 Jul; 203(1):W78-84. PubMed ID: 24951231
[TBL] [Abstract][Full Text] [Related]
12. Significance of the pseudocapsule on MRI of renal neoplasms and its potential application for local staging: a retrospective study.
Roy C; El Ghali S; Buy X; Lindner V; Lang H; Saussine C; Jacqmin D
AJR Am J Roentgenol; 2005 Jan; 184(1):113-20. PubMed ID: 15615960
[TBL] [Abstract][Full Text] [Related]
13. MR imaging features of small solid pseudopapillary tumors: retrospective differentiation from other small solid pancreatic tumors.
Yu MH; Lee JY; Kim MA; Kim SH; Lee JM; Han JK; Choi BI
AJR Am J Roentgenol; 2010 Dec; 195(6):1324-32. PubMed ID: 21098190
[TBL] [Abstract][Full Text] [Related]
14. Tumor grade estımatıon of clear cell and papıllary renal cell carcınomas usıng contrast-enhanced MDCT and FSE T2 weıghted MR ımagıng: radıology-pathology correlatıon.
Halefoglu AM; Ozagari AA
Radiol Med; 2021 Sep; 126(9):1139-1148. PubMed ID: 34100169
[TBL] [Abstract][Full Text] [Related]
15. Renal tubulocystic carcinoma is closely related to papillary renal cell carcinoma: implications for pathologic classification.
Zhou M; Yang XJ; Lopez JI; Shah RB; Hes O; Shen SS; Li R; Yang Y; Lin F; Elson P; Sercia L; Magi-Galluzzi C; Tubbs R
Am J Surg Pathol; 2009 Dec; 33(12):1840-9. PubMed ID: 19898225
[TBL] [Abstract][Full Text] [Related]
16. Small renal cell carcinoma: MRI with pathologic correlation.
Shinmoto H; Yuasa Y; Tanimoto A; Narimatsu Y; Jinzaki M; Hiramatsu K; Mukai M
J Magn Reson Imaging; 1998; 8(3):690-4. PubMed ID: 9626888
[TBL] [Abstract][Full Text] [Related]
17. MRI features of renal cell carcinoma that predict favorable clinicopathologic outcomes.
Doshi AM; Huang WC; Donin NM; Chandarana H
AJR Am J Roentgenol; 2015 Apr; 204(4):798-803. PubMed ID: 25794069
[TBL] [Abstract][Full Text] [Related]
18. Renal cell carcinoma: diffusion-weighted MR imaging for subtype differentiation at 3.0 T.
Wang H; Cheng L; Zhang X; Wang D; Guo A; Gao Y; Ye H
Radiology; 2010 Oct; 257(1):135-43. PubMed ID: 20713607
[TBL] [Abstract][Full Text] [Related]
19. Unenhanced CT and MRI Parameters That Can Be Used to Reliably Predict Fat-Invisible Angiomyolipoma.
Jeong CJ; Park BK; Park JJ; Kim CK
AJR Am J Roentgenol; 2016 Feb; 206(2):340-7. PubMed ID: 26797361
[TBL] [Abstract][Full Text] [Related]
20. Magnetic resonance imaging as a biomarker in renal cell carcinoma.
Pedrosa I; Alsop DC; Rofsky NM
Cancer; 2009 May; 115(10 Suppl):2334-45. PubMed ID: 19402070
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
